3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Glioblastoma
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Melanoma
1
Lung Neoplasms
1
Liver Failure
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Gliosarcoma
1
Glioma
1
Interventions
mogamulizumab
7
Specimen Handling
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
Biopsy
5
pembrolizumab
4
fludarabine
4
Magnetic Resonance Spectroscopy
4
Brentuximab Vedotin
4
hypericin
3
fludarabine phosphate
3
cemiplimab
3
Radiotherapy
3
Nivolumab
3
sodium-iodide symporter
2
X-Rays
2
Whole-Body Irradiation
2
Tacrolimus
2
Phototherapy
2
Photons
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Busulfan
2
talimogene laherparepvec
1
ruxolitinib
1
romidepsin
1
magrolimab
1
duvelisib
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mycosis Fungoides
×
veliparib
×
1 year
×
Clear all
No trials found.